ミクロトーム：市場洞察・競合環境・市場予測 (～2030年)

ミクロトームの市場規模は、2024年から2030年までの予測期間中にCAGR 6.43%で成長すると予測されています。

ミクロトームの需要は、主に癌、アテローム性動脈硬化症、心筋梗塞、心筋症などの心血管疾患、喘息、慢性閉塞性肺疾患 (COPD) などの呼吸器疾患などの慢性疾患の症例数の増加によって後押しされています。さらに、世界のバイオ医療研究と医薬品開発活動の拡大もミクロトームの需要に拍車をかけています。研究者は、分子診断、創薬、個別化医療のために高品質の組織切片を必要としており、このことが予測期間中のミクロトーム市場を押し上げています。

世界保健機関 (WHO) が2024年に提供したデータによると、国際がん研究機関 (IARC) は2022年に世界で新たに2,000万人の癌が登録されたと述べています。また、同機関によると、登録された新規の癌症例のうち、肺癌は世界で250万人の新規症例を占め、もっとも多い癌でした。次いで、乳癌が230万件、大腸癌が190万件、胃癌が97万件となっています。

Global Cancer Observatory (2024) は、2030年までに新たに発生する癌の症例数は、世界全体で2,000万人から2,410万人に達すると推定しています。さらに、アジアが982万6,539人、欧州が447万1,422人、ラテンアメリカ・カリブ海諸国が155万1,060人、アフリカが118万5,216人であるとしています。癌の診断と治療は正確な組織検査に大きく依存しているため、癌罹患率の上昇に伴い、顕微鏡分析用の高品質な組織切片を作成するためにミクロトームの普及が必要とされます。癌患者の急増は、ミクロトームの市場拡大につながっています。

WHOが提供したデータ (2024年) によると、2019年に喘息に罹患した人は2億6,200万人とされています。さらに、2023年には3億9,200万人が慢性閉塞性肺疾患 (COPD) に罹患しており、その4分の3は中低所得国に住んでいます。COPDは高度な診断と治療のニーズに拍車をかけています。ミクロトームは、病理組織検査用の薄い組織切片を作製することで、このような状況において重要な役割を果たしています。これらの切片は、肺組織の構造、炎症、病理学的変化を詳細に研究することを可能にしています。

当レポートでは、世界のミクロトームの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 ミクロトーム市場：イントロダクション

第2章 ミクロトーム市場：エグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 ミクロトーム市場：主要要因分析

• 市場促進要因
  • 慢性疾患の増加
  • R&D活動の増加
• 市場抑制要因・課題
  • 凍結切片作製やレーザーマイクロダイセクションなどの代替サンプル調製技術のアベイラビリティ
• 市場機会
  • 組織切片作成における効率化、人的ミスの低減、再現性の向上を実現するAI統合ミクロトームの開発

第6章 ミクロトーム市場：ポーターのファイブフォース分析

第7章 ミクロトーム市場：市場評価

• 製品別
  • デバイス
  • アクセサリー
• 技術別
  • 完全自動
  • 半自動
  • 手動
• エンドユーザー別
  • 病院
  • 診断クリニック
  • 学術・研究ラボ
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 ミクロトーム市場：企業および製品プロファイル

• Thermo Fisher Scientific Inc
• AGD Biomedicals Pvt. Ltd.
• SLEE medical GmbH
• Diapath S.p.A.
• Leica Biosystems Nussloch GmbH
• Green Leaf Scientific
• MEDITE Medical GmbH
• LLS ROWIAK LaserLabSolutions GmbH
• Amos Scientific PTY. LTD
• RWD Life Science Co
• Sakura Finetek
• Boeckeler Instruments, Inc.
• HACKER Instruments & Industries Inc
• microTec Laborgerate GmbH
• Bright Instrument Co Limited.
• JINHUA YIDI MEDICAL APPLIANCES CO.,LTD
• FEATHER Safety Razor Co., Ltd
• Precisionary Instruments
• Powered Milestone S.r.l.
• Weinkauf Medizintechnik

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項・お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Microtome Market in Global (2021-2030)
• Table 3: Microtome Market in Global by Product (2021-2030)
• Table 4: Microtome Market in Global by Technology (2021-2030)
• Table 5: Microtome Market in Global by End-User (2021-2030)
• Table 6: Microtome Market in Global by Geography (2021-2030)
• Table 7: Microtome Market in North America (2021-2030)
• Table 8: Microtome Market in the United States (2021-2030)
• Table 9: Microtome Market in Canada (2021-2030)
• Table 10: Microtome Market in Mexico (2021-2030)
• Table 11: Microtome Market in Europe (2021-2030)
• Table 12: Microtome Market in France (2021-2030)
• Table 13: Microtome Market in Germany (2021-2030)
• Table 14: Microtome Market in United Kingdom (2021-2030)
• Table 15: Microtome Market in Italy (2021-2030)
• Table 16: Microtome Market in Spain (2021-2030)
• Table 17: Microtome Market in the Rest of Europe (2021-2030)
• Table 18: Microtome Market in Asia-Pacific (2021-2030)
• Table 19: Microtome Market in China (2021-2030)
• Table 20: Microtome Market in Japan (2021-2030)
• Table 21: Microtome Market in India (2021-2030)
• Table 22: Microtome Market in Australia (2021-2030)
• Table 23: Microtome Market in South Korea (2021-2030)
• Table 24: Microtome Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Microtome Market in the Rest of the World (2021-2030)
• Table 26: Microtome Market in the Middle East (2021-2030)
• Table 27: Microtome Market in Africa (2021-2030)
• Table 28: Microtome Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Microtome Market in Global (2021-2030)
• Figure 3: Microtome Market in Global by Product (2021-2030)
• Figure 4: Microtome Market in Global by Technology (2021-2030)
• Figure 5: Microtome Market in Global by End-User (2021-2030)
• Figure 6: Microtome Market in Global by Geography (2021-2030)
• Figure 7: Microtome Market in North America (2021-2030)
• Figure 8: Microtome Market in the United States (2021-2030)
• Figure 9: Microtome Market in Canada (2021-2030)
• Figure 10: Microtome Market in Mexico (2021-2030)
• Figure 11: Microtome Market in Europe (2021-2030)
• Figure 12: Microtome Market in France (2021-2030)
• Figure 13: Microtome Market in Germany (2021-2030)
• Figure 14: Microtome Market in United Kingdom (2021-2030)
• Figure 15: Microtome Market in Italy (2021-2030)
• Figure 16: Microtome Market in Spain (2021-2030)
• Figure 17: Microtome Market in the Rest of Europe (2021-2030)
• Figure 18: Microtome Market in Asia-Pacific (2021-2030)
• Figure 19: Microtome Market in China (2021-2030)
• Figure 20: Microtome Market in Japan (2021-2030)
• Figure 21: Microtome Market in India (2021-2030)
• Figure 22: Microtome Market in Australia (2021-2030)
• Figure 23: Microtome Market in South Korea (2021-2030)
• Figure 24: Microtome Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Microtome Market in the Rest of the World (2021-2030)
• Figure 26: Microtome Market in the Middle East (2021-2030)
• Figure 27: Microtome Market in Africa (2021-2030)
• Figure 28: Microtome Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Microtome Market by Product (Microtome [Rotary Microtome, Vibrating Microtome, and Others] and Accessories [Blades and Knives, Cooling Clamp, Others]), Technology (Fully Automated, Semi-Automated, and Manual), End-User (Hospital, Diagnostic Clinics, Academic and Research Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing cases of chronic disorders, rise in research and development activities, among others globally

The microtome market is estimated to grow at a CAGR of 6.43% during the forecast period from 2024 to 2030. The demand for microtomes is primarily being boosted by the increasing cases of chronic disorders such as cancer, cardiovascular diseases including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), among others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2024 to 2030.

Microtome Market Dynamics:

According to data provided by the World Health Organization (WHO) in 2024, the International Agency for Research on Cancer (IARC) stated that 20 million new instances of cancer were registered in 2022 globally. Additionally, as per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer. Next in order of incidence was breast cancer with 2.3 million cases, colon cancer with 1.9 million cases, and stomach cancer with 0.97 million cases globally.

The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million by the year 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases. As cancer diagnosis and treatment rely heavily on accurate tissue examination, the rising cancer rates necessitate the widespread use of microtomes to prepare high-quality tissue sections for microscopic analysis. This surge in cancer cases translates into a larger market for microtomes.

According to data provided by the WHO (2024), in 2019 there were 262 million people affected by asthma. Additionally, in 2023, 392 million people were living with Chronic Obstructive Pulmonary Disorder (COPD) with three-quarters of them living in low and middle-income countries. COPD spurts the critical need for advanced diagnostic and treatment options. Microtomes play a vital role in this context by preparing thin tissue sections for histopathological examination. These sections allow the detailed study of lung tissue architecture, inflammation, and pathological changes, thereby boosting its market.

Therefore, all the above-mentioned factors such as the increasing instances of cancers and respiratory disorders are expected to drive the market for microtomes during the given forecast period.

However, the availability of alternative sample preparation technologies, such as cryo-sectioning and laser microdissection could reduce the reliance on traditional microtomes, acting as factors that are expected to limit their end-user base, thus restricting the growth of the microtome market during the forecast period.

Microtome Market Segment Analysis:

Microtome Market by Product (Microtome [Rotary Microtome, Vibrating Microtome, and Others] and Accessories [Blades and Knives, Cooling Clamp, Others]), Technology (Fully Automated, Semi-Automated, and Manual), End-User (Hospital, Diagnostic Clinics, Academic and Research Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the technology segment of the microtome market, the fully automated category of microtome is estimated to amass a significant revenue share in the microtome market in 2023. This can be attributed to the large patient population associated with various chronic disorders and the presence of a variety of products available to specific this category.

Fully automated microtomes offer several advantages and diverse applications, significantly enhancing the field of histopathology. Their primary benefits is to produce consistent high quality tissue sections with minimal user intervention, ensuring precision and reproducibility. This automation reduces the risk of human error and variability, which is crucial for accurate diagnosis.

In terms of applications, fully automated microtomes are invaluable in cancer diagnostics, where they provide fine tissue sections needed for detailed examination of tumor morphology and margins. They are also extensively used in research settings to study disease mechanisms at the cellular level, contributing to the development of new treatments and therapies. These advanced instruments are employed in various medical fields, including neuropathology, dermatopathology, and cardiovascular pathology, where precise tissue sectioning is critical for studying complex structures and diagnosing conditions.

Additionally, the presence of a huge number of commercially available fully automated systems and the increasing demand for digitalization in tissue diagnostic procedures are some of the crucial factors anticipated to boost the market in the next few years. Some of the key automated products include Microtome A550, Tissue-Tek Genie, and Leica Biosystems HistoCore AUTOCUT 2550.

Therefore, the various advantages and applications provided by fully automated microtomes will contribute to the growth of this category, thereby driving the growth of the overall microtome market during the forecast period.

North America Is Expected To Dominate The Overall Microtome Market:

North America is expected to account for the highest proportion of the microtome market in 2023, out of all regions. This is owing to the continual increase in cancer cases in the North America region, the growing myocardial infarction cases, and various lung-related disorders including COPD, among others. Moreover, the high-end medical infrastructure paired with readily available high-tech equipment, expanding prospects for sophisticated cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, rise in healthcare spending, presence of a large number of market players in the region are expected to drive the growth of the microtome market in North America.

National Cancer Institute (2024) estimated that 2 million new cases of cancer will be diagnosed in the US by the end of 2024. Furthermore, it is estimated that prostate, lung, and colorectal cancers are expected to represent approximately 48% of all cancer diagnoses in men. For women, the most prevalent cancers are breast, lung, and colorectal, which are expected to account for about 51% of all new cancer diagnoses.

According to Global Cancer Observatory's updated data (2024), in 2022, the US represented 89.1% of all cancer cases and Canada represented 10.9% of all cancer cases in the North America region. The reliance on microtomes for accurate tissue sectioning in cancer diagnosis and research is paramount. Microtomes are essential for producing high-quality tissue samples for identifying cancer types, understanding disease progression, and tailoring treatment plans. Consequently, the rising instances of cancer catalyze the demand for microtomes hence propelling market growth.

According to the recently updated data provided by the Centres for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. The high incidence of myocardial infarctions necessitates extensive histological examination of cardiac tissues to understand the underlying causes. Microtomes are essential in preparing thin, detailed sections of heart tissue for microscopic analysis, enabling pathologists to examine cellular structures, detect abnormalities, and evaluate the effectiveness of treatment therefore boosting its market growth.

According to the American Lung Association data updated in April 2024, it stated that more than 34 million people were living in the US with chronic lung diseases like asthma and COPD. These disorders underscore the growing need for microtomes in diagnostic pathology because of their ability to produce high-quality lung tissue sections for microscopic analysis which is vital for diagnosing, understanding, and treating these conditions, consequently boosting the market for microtomes.

Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North American microtome market growth during the forecast period from 2024 to 2030.

Microtome Market Key Players:

Some of the key market players operating in the Microtome market include Thermo Fisher Scientific Inc, AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co, Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgerate GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO., LTD, FEATHER Safety Razor Co., Ltd, Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others.

Recent Developmental Activities In The Microtome Market:

• In February 2023, Precisionary Instruments launched a brand new line of rotatory microtome and offered 3 models for the same; RF-600: Manual model, RF-800: Semi-automated model, RF-1000: Fully automated model.

Key Takeaways From The Microtome Market Report Study

• Market size analysis for current microtome market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the microtome market
• Various opportunities available for the other competitors in the microtome market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current microtome market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for microtome market growth in the coming future?

Target Audience Who Can Be Benefited From This Microtome Market Report Study

• Microtome product providers
• Research organizations and consulting companies
• Microtome-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in microtome
• Various end-users who want to know more about the microtome market and the latest technological developments in the microtome market.

Frequently Asked Questions For The Microtome Market:

1. What is microtome?

Microtomes are specialized devices designed to create thin, uniform sections of tissue or other samples, typically ranging from a few micrometers to tens of micrometers in thickness.

2. What is the market for microtome?

The microtome market is estimated to grow at a CAGR of 6.43% during the forecast period from 2024 to 2030.

3. What are the drivers for the microtome market?

The Microtome market is primarily being boosted by the increasing cases of chronic disorders such as cancer, cardiovascular diseases including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), among others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2024 to 2030.

4. Who are the key players operating in the microtome market?

Some of the key market players operating in Microtome include Thermo Fisher Scientific Inc, AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co, Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgerate GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO.,LTD, FEATHER Safety Razor Co., Ltd, Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others.

5. Which region has the highest share in the microtome market?

North America is expected to dominate the overall microtome market during the forecast period from 2024 to 2030. This is owing to the continual increase in cancer cases in the North America region, the growing myocardial infarction cases, and various lung-related disorders including COPD, among others. Moreover, the high-end medical infrastructure paired with readily available high-tech equipment, expanding prospects for sophisticated cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, rise in healthcare spending, and presence of a large number of market players in the region are expected to drive the growth of the microtome market in North America.

Table of Contents

1. Microtome Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Microtome Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Microtome Market Key Factors Analysis

• 5.1. Microtome Market Drivers
  • 5.1.1. Growing cases of chronic disorders
  • 5.1.2. Rise in research and development activities
• 5.2. Microtome Market Restraints and Challenges
  • 5.2.1. Availability of alternative sample preparation technologies, such as cryo-sectioning and laser microdissection
• 5.3. Microtome Market Opportunities
  • 5.3.1. Development of AI integrated microtomes for efficiency, less human errors, and better reproducibility in tissue sectioning

6. Microtome Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Microtome Market Assessment

• 7.1. By Product
  • 7.1.1. Devices
    • 7.1.1.1. Rotary Microtome
    • 7.1.1.2. Vibrating Microtome
    • 7.1.1.3. Others
  • 7.1.2. Accessories
    • 7.1.2.1. Blades and Knives
    • 7.1.2.2. Cooling Clamp
    • 7.1.2.3. Others
• 7.2. By Technology
  • 7.2.1. Fully Automated
  • 7.2.2. Semi-Automated
  • 7.2.3. Manual
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Diagnostic Clinics
  • 7.3.3. Academic and Research Laboratories
  • 7.3.4. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Microtome Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Microtome Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Microtome Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Microtome Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Microtome Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Microtome Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Microtome Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Microtome Market Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Microtome Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Microtome Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Microtome Market Size in USD million (2021-2030)
    • 7.4.3.3. India Microtome Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Microtome Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Microtome Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Microtome Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Microtome Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Microtome Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Microtome Market Size in USD million (2021-2030)

8. Microtome Market Company and Product Profiles

• 8.1. Thermo Fisher Scientific Inc
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. AGD Biomedicals Pvt. Ltd.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. SLEE medical GmbH
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Diapath S.p.A.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Leica Biosystems Nussloch GmbH
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Green Leaf Scientific
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. MEDITE Medical GmbH
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. LLS ROWIAK LaserLabSolutions GmbH
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Amos Scientific PTY. LTD
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. RWD Life Science Co
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Sakura Finetek
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Boeckeler Instruments, Inc.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. HACKER Instruments & Industries Inc
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. microTec Laborgerate GmbH
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Bright Instrument Co Limited.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. JINHUA YIDI MEDICAL APPLIANCES CO.,LTD
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. FEATHER Safety Razor Co., Ltd
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Precisionary Instruments
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Powered Milestone S.r.l.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Weinkauf Medizintechnik
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us